Showing 1 to 2 of 2 results


PromarkerD: Predictive Diabetic Kidney Disease Test Launches in Australia
Proteomics International Laboratories launched its PromarkerD predictive test for diabetic kidney disease in Australia on World Kidney Day, initially in Western Australia and the Northern Territory, costing $245 per test and aiming for nationwide rollout and global expansion.
PromarkerD: Predictive Diabetic Kidney Disease Test Launches in Australia
Proteomics International Laboratories launched its PromarkerD predictive test for diabetic kidney disease in Australia on World Kidney Day, initially in Western Australia and the Northern Territory, costing $245 per test and aiming for nationwide rollout and global expansion.
Progress
48% Bias Score

Proteomics International Secures \$2.16 Million R&D Rebate for Diagnostic Blood Tests
Proteomics International secured a \$2.16 million Australian R&D tax rebate to commercialize its innovative blood tests for diabetic kidney disease, endometriosis, and esophageal cancer, leveraging a \$4.95 million R&D investment and aiming for US market entry.

Proteomics International Secures \$2.16 Million R&D Rebate for Diagnostic Blood Tests
Proteomics International secured a \$2.16 million Australian R&D tax rebate to commercialize its innovative blood tests for diabetic kidney disease, endometriosis, and esophageal cancer, leveraging a \$4.95 million R&D investment and aiming for US market entry.
Progress
40% Bias Score
Showing 1 to 2 of 2 results